Scholar Rock announced the appointment of David L. Hallal as its new Chief Executive Officer, succeeding Jay Backstrom, M.D. Mr. Hallal previously served as Chairman of Scholar Rock's Board of Directors since 2017 and brings extensive experience from his decade-long tenure as CEO, COO, and CCO of Alexion.
This planned leadership transition aims to accelerate Scholar Rock's evolution into a global biotech leader, particularly as it prepares for the potential commercial launch of apitegromab. Dr. Backstrom will continue to serve as a strategic advisor to the executive team and Board.
In addition to Mr. Hallal's appointment, Scholar Rock announced the addition of three other key leaders: Akshay Vaishnaw, R. Keith Woods, and Vikas Sinha. These appointments are intended to scale the organization for its next phase of growth and global commercialization efforts.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.